L. James

Phase II randomized study of ixabepilone vs. observation in patients with significant residual disease after neoadjuvant systemic therapy for HER2-negative breast cancer

G. Hortobagyi, V. Valero, N. Ibrahim, 2015 .

Phase 2 Study of Ibrutinib in Classic and Variant Hairy Cell Leukemia.

Jeffrey A Jones, M. Grever, G. Lozanski, 2021, Blood.

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.

W. Wilson, S. Steinberg, M. Raffeld, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.